The new Karizoo Laboratories newsletter
CITRAMOX® L.A. 150 mg/ml suspension for injection
Laboratorios Karizoo S.A introduces CITRAMOX® L.A. 150 mg/ml suspension for injection HIGHLY FLUID for cattle and pigs on the nacional and internacional market.
Indicated for the treatment of respiratoy infections.
Withdrawal…
HALOFUSOL® 0,5 mg/ml oral solution
Laboratorios Karizoo S.A introduces HALOFUSOL® 0,5 mg/ml oral solution on the nacional and internacional market.
The enemy of bovine cryptosporidiosis.
Proven preventive and curative efficacy in calves.
Withdrawal period: 13 days.
Packaging:…
EUROTIER 2024
We conclude another successful EuroTier, and we want to express our gratitude to everyone who made this important event possible.
Thank you to everyone who visited us. EuroTier always represents a unique opportunity to connect with partners,…
Alivira Spain expands its international presence with Urixine®
Alivira Spain continues its international expansion with the launch of its phenylpropanolamine-based product in several European countries. Following its successful establishment in Spain and Russia, the company will introduce Uristop®, under…
GLOBAL FORMULATION CONVENTION
From May 27 to 30, the Alivira group held the second Global Formulation Convention in Antalya, Turkey. More than 40 participants from different countries and continents gathered in Turkey for this annual meeting.
It was 4 days of work meetings,…
COMPANIES REPRESENTED IN SPAIN
Laboratorios Karizoo S.A.
An Alivira Group Company
P. I. La Borda Mas Pujades 11-12
Oficina y logística
P. I. La Borda, Borges Blanques 21-25
08140 Caldes de Montbui
Barcelona (España)
T +34 938 654 148
F +34 938 654 648
www.alivira.es
karizoo@alivira.es
Communication in case of adverse events with Karizoo products: pharmacovigilance@alivira.es